Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Qualigen Therapeutics, Inc. Common Stock (QLGN)

Annual Return

Over the past 3 years, QLGN has had an average annual return of +0%, underperforming the benchmark SPY, which returned +22.77% annual.

Over the past 5 years, QLGN has had an average annual return of -66.63%, underperforming the benchmark SPY, which returned +14% annual.

Over the past 10 years, QLGN has had an average annual return of -66.01%, underperforming the benchmark SPY, which returned +15.53% annual.

Since Jun 24, 2015, QLGN has had an average annual return of -66.26%, underperforming the benchmark SPY, which returned +14.30% annual.

202320222021202020192018201720162015
+0%-88.89%-62.50%-29.41%-71.90%-81.75%-87.87%+59.44%-65.73%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2023+0%+0%+0%+0%+0%+0%+0%+0%+0%+0%+0%+0%+0%
2022-22.22%-28.57%+0%+0%+0%+0%-40.00%+0%-33.33%+0%-50.00%+0%-88.89%
2021+12.50%+0%-18.52%-22.73%-11.76%+6.67%-12.50%-7.14%-23.08%-10.00%+33.33%-25.00%-62.50%
2020+23.53%+230.95%-61.15%+20.37%-20.00%-38.46%+43.75%-15.22%+2.56%-22.50%-9.68%-14.29%-29.41%
2019-1.65%+6.72%+38.58%-11.36%+14.10%+21.35%-3.70%-0%-69.71%-17.46%-30.77%-5.56%-71.90%
2018-0.30%-18.00%+1.11%+0.73%+31.52%-28.65%-15.06%-8.41%-6.95%-38.13%-22.84%-32.40%-81.75%
2017+26.19%-25.15%-44.53%-43.66%-23.12%-10.56%+1.80%+1.77%-38.56%+4.53%-12.33%+2.47%-87.87%

Drawdown analysis of Qualigen Therapeutics, Inc. Common Stock (QLGN)

The maximum drawdown for the QLGN was -99.99%, occurring on Nov 22, 2022. This drawdown has not yet recovered.

The current QLGN drawdown is -99.99%.

Since Jun 24, 2015 QLGN has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 1 time
DepthStartTo BottomBottomTo RecoverEndTotal
-99.99%Jun 24, 20151868Nov 22, 2022OngoingOngoingOngoing